Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Meixuan Chen
Institution:
Yantaishan Hospital
Observed institutions:
Durham University,
Tianjin Medical University Cancer Institute and Hospital,
University of Bristol,
Yantaishan Hospital,
Poseida Therapeutics (United States),
Arizona State University,
Tianjin Medical University
show all 7
ORCID:
0000-0002-7957-0721
Observed ORCID:
0000-0002-7957-0721
OpenAlex ID:
A5101633310
The neoepitope landscape of breast cancer: implications for immunotherapy
2019
·
Pooja Narang
, Meixuan Chen
, et al.
·
BMC Cancer
·
97
The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers
2018
·
Michael T. Barrett
, Elizabeth Lenkiewicz
, et al.
·
Breast Cancer Research
·
77
PDF
JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer
2018
·
Meixuan Chen
, Barbara Pockaj
, et al.
·
Clinical Breast Cancer
·
75
PDF
Antimicrobial resistance, inflammatory responses: a comparative analysis of pathogenicities, knowledge hybrids and the semantics of antibiotic use
2019
·
Helen Lambert
, Meixuan Chen
, et al.
·
Humanities and Social Sciences Communications
·
34
PDF
Pathways to optimising antibiotic use in rural China: identifying key determinants in community and clinical settings, a mixed methods study protocol
2019
·
Linhai Zhao
, Rachel Marie Kwiatkowska
, et al.
·
BMJ Open
·
29
PDF
Prescribing Antibiotics in Rural China: The Influence of Capital on Clinical Realities
2020
·
Meixuan Chen
, Paul Kadetz
, et al.
·
Frontiers in Sociology
·
27
PDF
Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification
2017
·
Meixuan Chen
, Mariacarla Andreozzi
, et al.
·
Modern Pathology
·
27
PDF
The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers
2022
·
Karen S. Anderson
, Timothy K. Erick
, et al.
·
Breast Cancer Research and Treatment
·
25
PDF
Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population
2015
·
Tong Wang
, Yuanyuan Ma
, et al.
·
Tumor Biology
·
7
P-CD19CD20-ALLO1: Potent Fully Allogeneic CAR-T Therapy Targeting CD19 and CD20 with Superior Efficacy over Single-Target Products
2024
·
Samy Jambon
, Jennifer Ruiz
, et al.
·
Blood
·
2
Myeloid/Lymphoid Neoplasm With ETV6 :: ABL1 Fusion Mimicking Chronic Myeloid Leukemia
2026
·
Hongwei Chen
, Meixuan Chen
, et al.
·
International Journal of Laboratory Hematology
IgD Myeloma Mimicking Lymphoma: A Diagnostic Pitfall
2026
·
Linmeng Li
, Meixuan Chen
, et al.
·
Indian Journal of Hematology and Blood Transfusion
Auer Rod–Like Inclusions in T-cell Large Granular Lymphocytic Leukaemia
2025
·
Hongwei Chen
, Meixuan Chen
·
Indian Journal of Hematology and Blood Transfusion
Acute Myeloid Leukemia with MECOM Rearrangement Presenting with Striking Hemophagocytosis
2025
·
Hongwei Chen
, Meixuan Chen
·
Indian Journal of Hematology and Blood Transfusion
Abstract 4093: Synergy of CTL tumor cytotoxicity with myxoma oncolytic virotherapy
2019
·
Meixuan Chen
, Ana L. Matos
, et al.
·
Cancer Research
Abstract 4093: Synergy of CTL tumor cytotoxicity with myxoma oncolytic virotherapy
2019
·
Meixuan Chen
, Ana L. Matos
, et al.
·
Immunology
Key influences of antibiotic use in China
2017
·
Fengrui
, Meixuan Chen
, et al.
·
OSF Preprints (OSF Preprints)
Show more works
View as search
Works count:
17
Citation count:
400
H-index:
8
I10-index:
8
Year
Topic
Type
